Active ingredient
- influenza vaccine (recombinant, prepared in cell culture)
Legal Category
POM: Prescription only medicine
POM: Prescription only medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.
Below is a text only representation of the Patient Information Leaflet. The original leaflet can be viewed using the link above.
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PLGB 04425/0879 .
Supemtek solution for injection in pre-filled syringe
Package Leaflet – Information for the User
Supemtek
Solution for injection in pre-filled syringe
Quadrivalent Influenza Vaccine (recombinant, prepared in cell culture)
▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side affects you may get. See the end of section 4 for how to report side effects.
Read all of this leaflet carefully before you receive this medicine because it contains important information for you.
What is in this leaflet:
1. What Supemtek is and what it is used for
2. What you need to know before you receive Supemtek
3. How Supemtek is given
4. Possible side effects
5. How to store Supemtek
6. Contents of the pack and other information
1. What Supemtek is and what it is used for
Supemtek is a vaccine for adults who are 18 years of age and older. This vaccine helps to protect you against flu (influenza). Supemtek is egg-free because of the technology used to produce it.
How Supemtek works
When a person is given Supemtek, the body’s natural defence (the immune system) produces protection against the influenza virus. None of the ingredients in the vaccine can cause flu. As with all vaccines, Supemtek may not fully protect all persons who are vaccinated.
When to have a flu vaccine
Flu can spread very fast.
Your doctor will be able to recommend the best time to be vaccinated.
2. What you need to know before you receive Supemtek
Do not use Supemtek if you are allergic to :
Warnings and precautions
Talk to your doctor, pharmacist or nurse before receiving Supemtek.
As with all vaccines, Supemtek may not fully protect all persons who are vaccinated.
Before receiving the vaccine, tell your doctor, nurse or pharmacist if:
If any of the above apply to you (or you are not sure) talk to your doctor, pharmacist or nurse before receiving Supemtek.
Other medicines and Supemtek
Tell your doctor or nurse if you are using, have recently used or might use any other medicines, including medicines obtained without a prescription or if you have recently received any other vaccine.
Supemtek may be given at the same time as other vaccines by using separate limbs.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this vaccine. Your doctor or pharmacist will help you to decide if you should receive Supemtek.
Driving and using machines
Supemtek has no or negligible effect on your ability to drive and use machines.
Supemtek contains sodium
This vaccine contains less than 1 mmol sodium (23 mg) per dose, this means that it’s essentially ‘sodium free’.
3. How Supemtek is given
Supemtek is given to you by your doctor, nurse or pharmacist as an injection into the muscle at the top of the upper arm (deltoid muscle).
Adults from 18 years of age and older:
One dose of 0.5 mL.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Severe allergic reactions
Contact your doctor or healthcare professional immediately or go to the nearest hospital emergency room right away if you have an allergic reaction. It can be life-threatening.
Symptoms include:
The following side effects have been reported with Supemtek:
Other side effects
Very common (may affect more than 1 in 10 people):
Muscle pain and joint pain are common in adults aged 50 years and older.
Common (may affect up to 1 in 10 people):
Fever is rare in adults aged 50 years and older.
Uncommon (may affect up to 1 in 100 people):
Itching is rare in adults aged 50 years and older.
Skin irritation and rash have not been reported in adults aged 50 years and older.
Flu-like symptoms has not been reported in adults aged 18-49 years.
Rare (may affect up to 1 in 1000 people):
Feeling dizzy and hives have not been reported in adults aged 18-49 years.
Not known (cannot be estimated from the available data):
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system (see details below). By reporting side effects, you can help provide more information on the safety of this medicine.
United Kingdom
Medicines and Healthcare products Regulatory Agency (MHRA):
Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
5. How to store Supemtek
Keep this vaccine out of the sight and reach of children.
Store in a refrigerator (2°C - 8°C). Do not freeze.
Keep the pre-filled syringe in the outer carton in order to protect from light.
Do not use this vaccine after the expiry date which is stated on the label and carton after EXP.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. Contents of the pack and other information
What Supemtek contains
One dose (0.5 mL) contains:
The active substances are influenza virus haemagglutinin (HA) proteins, of the following strains*:
A/Wisconsin/588/2019 (H1N1) - like strain
(A/Wisconsin/588/2019) ............................................ 45 micrograms HA
A/Cambodia/e0826360/2020 (H3N2) - like strain
(A/Tasmania/503/2020) ................................................. 45 micrograms HA
B/Washington/02/2019 - like strain
(B/Washington/02/2019) ................................................ 45 micrograms HA
B/Phuket/3073/2013 - like strain
(B/Phuket/3073/2013) .................................................... 45 micrograms HA
* produced by recombinant DNA technology using a baculovirus expression system in a continuous insect cell line that is derived from Sf9 cells of the fall armyworm, Spodoptera frugiperda.
This vaccine complies with the World Health Organisation (WHO) recommendation (northern hemisphere) and EU recommendation for the 2021/2022 season.
The other ingredients are: polysorbate 20 (E432), sodium chloride, sodium phosphate monobasic monohydrate, sodium phosphate dibasic dodecahydrate, water for injections.
What Supemtek looks like and contents of the pack
Supemtek is a solution for injection in a pre-filled syringe (ready to use syringe).
Supemtek is a clear and colourless solution.
A single syringe contains 0.5 mL of solution for injection.
Supemtek is available in packs containing 1, 5 or 10 pre-filled syringes without needle or with separate needle.
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Manufacturer
This leaflet was last revised in 07/2021.
410, Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
+44 (0)800 035 2525